Podcasts about Cros

This episode focuses on disparity in clinical trial participation between patient populations, industry innovations to improve health equity, the accelerated movement towards decentralised trials – and what all this means for patient accessibility, diversity and engagement.    Our host LaQuinta Jernigan, Chief Operating Officer at mdgroup, speaks with Adam Samson, Head of Clinical Delivery Operations, RWE Clinical Trials at Walgreens, to understand the importance of trial design for health equity.   Adam is an expert at conducting clinical trials across multiple therapeutic areas as a coordinator, monitor, project manager, and executive within academia, sites, CROs, pharma, tech, and retail pharmacy. He currently serves as Head of Clinical Delivery Operations at Walgreens where his primary role is to operationalise existing locations to conduct clinical trials.   Adam also serves as adjunct faculty at The George Washington University in the Master's in Clinical Research Administration program, as well as serving as a core member in the Decentralized Trials & Research Alliance (DTRA) working group to map the participant journey in decentralised clinical trials.

"It's one thing having an idea, but you've got to be able to make it and you've got to be able to sell it." Just one extract from a wealth of sound advice offered by Ian Pike, Chief Scientific Officer at Proteome Sciences, on the Careers in Discovery podcast. Ian also talked to us about how CROs have become a crucial part of drug discovery, the importance of serendipity, his one career regret and being willing to pivot in your vision for your working life. Enjoy!

Thinking about leaving clinical medicine, but worried about downsides? If you're wondering if you'll regret leaving clinical medicine, listen to this episode, and hear some concerns and questions from a listener like you.In this episode of The Career Rx we'll discuss:Questions you should ask yourself about nonclinical medicineWorries and fears physicians have around nonclinical career changesMyths that hold doctors back from pursuing nonclinical careersToday we take a deep dive into a listener's question about the experiences and expectations of possible regret when going from clinical to nonclinical. Listen along, and ask yourself these questions to help you decide whether leaving clinical medicine for a nonclinical physician career is right for you.Special announcement: My course, Industry Insider, is now accredited for up to 12 CME credits. Learn how to land an exciting and impactful role as a physician in the world of pharma, biotech, or medical devices, AND how to do that even if you think you're not qualified, don't have any connections, or concerned about a pay cut… I've got you covered!In this Episode: [2:40] Normalizing fears that come with transitioning to nonclinical[6:30] Will you be bored? Will you find balance?[9:35] How final is this decision, or is there a way back?[14:20] What about job security? [16:20] Once a physician, always a physicianLinks and Resources: #88 - What Physicians Do in Pharma: Drug Discovery and Development#89 - Physician Jobs in Pharma: Medical Affairs#90 - Physician Jobs in Pharma: Clinical Research and CROs#91 - Physician Jobs in Pharma: Drug Safety and PharmacovigilanceThe Branding Rx - 18 hours of CME, mastering digital strategies for advancing your career, building your business, and growing your professional brand Support the show

In this very special live supersized episode not only do Karl & Vinnie make their nominations for creepiest “Karl & Vinnie” they are joined by the coolest of the Creepos and a cornucopia of creepy special guests like The Cardiff Electric Podcast, Dr. Steve, Pat Dixon, Cros, Trucker Andy, Justin Brown, Tucker Dixon and the voice of Syracuse Brian McBride. Listen as we march through Rochester in the scum parade and prove beyond a shadow of a doubt, we are the best true crime podcast in a brand-new edition of “Who are these Creeps”. We also included a hilarious “Pedophile Hunter Theater” segment, a live creep report and your listener voicemail roasts! To hear the “Official Roast of Karl & Vinnie” join us at https:/www.Patreon.com/ThecreepoffScum Parade Stories Predatory offender upset by pedophile bumper sticker; shoots out windows of vehicle | Community | hometownsource.comMan who demanded girlfriend to take nude pic of her mother jailed (yahoo.com)Tiger mum arrested after ‘poisoning child's classroom rival' in India | The IndependentMan breaks into ex's home, dumps ashes of deceased child into trash: Mt. Pleasant PD | WCIV (abcnews4.com)Pedophile Hunter Theater Videos: Pred who invited kid! Escapes in TINY CAR! And he won't stop! - YouTube(32) PvP Educational Catch Interview 150 Justin ARRESTED CRASHED CAR - YouTube

Do you ever have that feeling that the data is just… lacking?  It's really not going to be possible to effectively serve all partners if the data just doesn't serve the end goals. Part of that journey is transforming go to market by providing a robust 1st, 2nd, and 3rd party data plan. The best way to do that is ending the one size fits all product, and asking the simple question: how can this product serve your workflow, not ours?  Join us as we discuss: The role of community in go to market What good data looks like CRO rules of engagement     Here are some additional episodes featuring other ecosystem leaders that might interest you:  #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.   Links & Resources  Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com   This episode of Ecosystem Aces is sponsored by WorkSpan.   WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline. 

LA County Supervisor's search warrant // Crozier Rock City / Walmart in Banking business / Ryan Reynolds colonoscopy // Queens unique style / Queen procession to lie instate // Dodgers / Inflation weighing on Americans / Meat reason for the season

durée : 00:02:10 - L'Humeur du matin par Guillaume Erner - Gorbatchev, The Queen, William Klein, maintenant Godard, et je suis sûr qu'il y en aura d'autres, cet espace ne peut pas être dévolu à pleurer les petits anges partis trop tôt comme on dit dans les mauvaises rédactions.

This week Karl is traveling back from Los Angelos so Vinnie is joined by Brian Mcbride & Cros to nominate the biggest creeps in the British Royal Family: In the scum parade we learn why you should never bring cash to buy something from someone online, that sandwiches aren't free and that sometimes pedo's don't fall far from the tree.Please consider supporting the show and get free merch & monthly bonus episodes Check out this weeks scum parade stories New Port Richey officer fired amid allegations of fondling girl in custody (tampabay.com)Kingsburg father and two adult sons arrested for alleged sexual assault of young children (yahoo.com)A reporter who investigated a Las Vegas county official was killed. Police just arrested the official in connection to the reporter's death. (yahoo.com)Denver man convicted of killing couple who responded to online car ad | Truecrimedaily.com

Science 37 is a publicly traded pioneer in decentralized clinical trials, which offers an end-to-end 'operating' system for trial sponsors and CROs. The company leverages its various networks to enable hybrid and fully decentralized trials. The decentralized model also helps foster diversity and inclusion, which has become an important selling point.

Warren Zenna is the Founder & CEO of The CRO Collective, a Sales consultancy, training program, and community that helps CROs succeed. He is the host of the “CRO Spotlight” show Warren dons B2B buyers' flip flops to share buying preferences for Marketing + Sales: ✅aware of vendors via peers/network/referrals/WOM/influencers via content/social/communities (tks to Marketing + Marketing's influence on peers) ✅learn about/try/buy vendors via peers and website (tks to Marketing) w/OPTION for Sales ❌Turn off + tune out: telemarketing, email spam, LinkedIn spam, bribery via gift cards (Sales Development)

You can't be everywhere all at once. But your partnership network can. A good ecosystem will not only increase your sphere of influence and knowledge, but will be cheaper, increase sales conversions, and extend retention rates. That's why hearing what Mike Stocker, VP, Partnerships, RollWorks at NextRoll, Inc., has to say is important. Join us as we discuss: Delivering customer value with integrated partner solutions Real world examples of partner co-selling driving more revenue How partner influence delivers tangible and measurable results Here are some additional episodes featuring other ecosystem leaders that might interest you: #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.  Links & Resources Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds   To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com This episode of Ecosystem Aces is sponsored by WorkSpan.  WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline. 

Chatting with CEOs and CROs is enlightening and valuable, but sometimes you need practical and actionable tips from someone who's down in the trenches. Dave Phelps, RSM at Crowdstrike joins us this episode to give us expert advice on owning your territory and knowing your customers.Dave walks us through his process for planning and working a territory and doing research before meetings. He shares his mindset on approaching a territory like your own franchise, and offers a five-step plan for building an actionable business plan.Whether you're a junior seller or an account manager with years experience, tune in for real insight from one of the best in the business, and learn how to take your sales game to the next level.You'll Learn:What to do when you take over a new territoryHow to develop a meaningful ranking system for your accountsWhy building your customer profiles mattersHow to approach a 10kThe emotional vs. logical reasons your customers buySupport the show

Wed, 31 Aug 2022 03:45:00 +0000 https://jungeanleger.podigee.io/339-borsepeople-im-podcast-s122-thomas-tschol c2e2c42ce9922ef123aab09c04feea80 Mit Thomas Tschol, Co-Founder und Partner unseres Season-1-Presenters Management Factory, endet auch die Season 1 mit 22 Folgen. Der Vorarlberger, der u.a. in Toulouse und Berlin studiert hat, war in den späten Neunzigern bei Ernst & Young tätig und gründete dann mit Kollegen und Wegbegleitern die Manangement Factory, deren Assets „CFOs und CROs to Rent“ sind. Wir sprechen über Tätigkeiten bei Trenkwalder, Mayr Melnhof Holz, Zumtobel und Kreisel Electric in der John Deere Ära. Ich frage Thomas auch zum Thema IPO Begleitung und sage Danke für den Support der Season 1. http://mf.ag About: Die Serie Börsepeople findet m Rahmen von http://www.christian-drastil.com/podcast statt. Es handelt sich dabei um typische Personality- und W erdega ng -Gespräche. Die Season 1 umfasst unter dem Motto „22 Börsepeople in Summer 22“ eben 22 Po dcast-Talks, divers zusammengesetzt. Presenter ist die Management Factory (https://www.mf.ag ). Bewertungen bei Apple (oder auch Spotify) machen mir Freude: https://podcasts.apple.com/at/podcast/christian-drastil-wiener-börse-sport-musik-und-mehr-my-life/id1484919130 . 339 full no Christian Drastil Comm.

With increasing digitization, the threat of cyber attacks is also rising and so is the demand for IT security experts. According to the latest Risk & Cybersecurity Study by IT business Tata Consultancy Services (TCS), companies see the biggest challenge in cybersecurity not in the budget, but in the lack of professionals with relevant expertise. According to the study, half of European companies (49 per cent) plan to hire professionals with cybersecurity skills in the future, with that figure rising to two-thirds (65 per cent) in the US. Skills shortage among top challenges for cybersecurity Chief risk officers (CROs) and chief information security officers (CISOs) report in the survey that they have already had difficulty attracting (44 per cent) and retaining (42 per cent) talent with cyber risk and security skills in the past year. The second biggest challenge according to the CROs and CISOs is a changing work environment with increased possibilities for remote work and the associated risks. For example, innumerable employees had to be given remote access to their employer's systems and databases at short notice due to the pandemic and the resulting move to remote work. This opens up new points of attack for cybercriminals. Assessing security risks and quantifying their costs is the third biggest obstacle for the respondents. Cybersecurity not a budget issue Only tenth place in the ranking are budget constraints. The fact that the latter are affecting fewer and fewer companies is shown by the high level of willingness to invest: 52 per cent of European companies and 62 per cent of North American companies stated that they had increased their budgets for IT security since last year. Commenting on the study's findings, Gerard Grant, Director, Strategic Initiatives at TCS Ireland said “Keeping abreast of the most advanced tactics of cyber criminals is not a question of cost. Rather, the challenge lies in finding and retaining the right professionals with the required know-how.” TCS employs over 1,100 people in Ireland across a range of high-skilled tech related roles. TCS operates a state-of-the-art Global Delivery Centre based in Letterkenny which includes an innovation lab and plans are now in place for building further business units, together with centres of excellence in cyber security and cloud services. How companies ensure they have a recruiting edge One measure alone can't solve the skills shortage. “However, companies can help fill the skills gap by using external service providers for harder-to-staff work, such as 24/7 network monitoring, while growing talent internally by giving them exposure to not only the technical but the business aspects of cybersecurity,” says Gerard Grant. In addition, the study shows that the more frequently the board of directors engages in cybersecurity, the more successful the company is in finding and holding onto their top talent with cyber risk and security skills. TCS' study also finds that talent retention directly correlates with how a company stores its information. Cloud-positive organizations were found to have a slight advantage in retaining and recruiting talent with notoriously hard-to-find cyber skills, compared to those companies who think that on-premises or traditional data centre security is preferable to what is available via the cloud. In fact, embracing cloud platforms gives companies a five-point advantage in recruiting and retaining talent with cyber risk and security skills. “As businesses look to keep up with rapidly evolving complexities in cybersecurity, the talent gap is widening,” said Bob Scalise, Managing Partner, Risk and Cyber Strategy, TCS. “Demonstrating a serious commitment to cybersecurity by sustained attention from senior leadership, funding, and process changes will be vital to recruiting and retaining top talent.” The TCS Risk & Cybersecurity Study, published by the TCS Thought Leadership Institute, highlights the most pressing cybersecurity iss...

Hi, I'm Tom Rhoads, CEO of Spencer Health Solutions. We are proud of the amazing work that pharmacies do to support patient health and wellbeing. The need for innovation in the clinical trial ecosystem has challenged traditional pharmacies to rethink their strategy since they are the ones with the greatest access to a diverse and underserved population. On this episode of People Always, Patients Sometimes, we hear from a member of the clinical trials team at Walgreens that recently announced a corporate launch into providing clinical trial services at neighborhood store locations. Adam Sampson, head of clinical delivery operations for Walgreens is one of the team members tasked with managing the plan at clinical trial services to brick and mortar locations by the end of the year. I hope you enjoy this conversation on People Always, Patients Sometimes.   Janet Kennedy: (00:53) Hi, I'm Janet Kennedy and a member of the Spencer Health Solutions team. I'm looking forward to speaking with today's podcast guest, Adam Samson on People Always, Patients Sometimes. Adam is the Head of Clinical Delivery Operations for Walgreens, and he has a really big project in front of him. Welcome to the podcast, Adam!   Adam Samson: (01:12) Thanks so much, Janet. I really appreciate you having me on the show.   Janet Kennedy: (01:15) Well, you know, we've heard a little bit about you from my CEO, Tom Rhoads, but I'd really like to figure out how you got where you are today, especially from your startup background. So do you mind giving us a little bit of a catch up with your career and how you ended up where you are today?   Adam Samson: (01:31) Yeah, I'd be glad to. So I started my career in clinical trials as many people do, you know the cliches - to say that we kind of fell into the industry. I was a registered dietician out of undergrad and very quickly found my way into interacting directly with patients as part of clinical trials and worked as a clinical research coordinator for a few years and transitioned from there about 10 years ago into the more business side of our industry. So I worked at a couple mid-size CROs, took a very standard path. I was a regional monitor, worked in project management in line management. And then about seven years ago, my wife and I moved out here to North Carolina and I worked at Duke Clinical Research Institute for a few years. While at Duke, I did a lot of work in government funded trials in the pediatric space and completed a master's degree through George Washington in clinical trials.   Adam Samson: (02:28) And then I moved to a large pharma company and was conducting global, late phase studies. And then the pandemic hit, like many of us, I was, scrambling to keep my study going. You know, it's a hundred sites in eight countries. And how do we, possibly kind of keep operations, running lots of challenges. It was an eye opening experience around how in this industry, we really are under utilizing technology. That's no surprise to anyone we've gotten a bit better, but especially at that time, the start of the pandemic, getting even things like e-consent and other things approved was very challenging. So I decided to kind of take a leap of faith and join a very small time startup that was in the decentralized clinical trial space and had a great software product, but wanted to really build out their services and operations.   Adam Samson: (03:22) I joined the team when there were about 15 people and was with the team until series B and about 130 people. It was a really exciting couple years and enjoyed working in that space of how do we bring trials into patients homes and give them additional options to participate in trials? The one thing that remains a pervasive challenge when we're trying to do decentralized trials is that technology of course, is not enough. Sometimes patients there's a lack of trust. If things come through via email or they see them on the internet, not everybody wants somebody in their home. Sometimes people want to, go to a trusted healthcare provider, that's local to them. So when I saw this opportunity open up at Walgreens recently, where Walgreens was getting into the clinical trials business kind of light bulb went off, I'd been watching what's happening just overall in the retail pharmacy space.   Adam Samson: (04:16) And, I saw this as just an incredible opportunity to be able to take what I had learned across my career and kind of running trials in the traditional site based model, as well as, more recently working in the decentralized trials model and saying, "What if, we can take the best of both?" And we've got the technology and Walgreens has 9,000 approximately stores in the US. So 78% of the, the us population is within five miles of the Walgreens. What if we can take and plug clinical trials into that, right? There's the existing trust within the Walgreens brand and with the pharmacists that these patients are seeing every day. And we can really build a model on a really strong foundation that Walgreens has started to build in the healthcare space. So I joined the team as Head of Clinical Delivery Operations, as you said. And my role here is really to operationalize our stores, our physical footprint. How do we make sure that we have the right people process and technologies to be able to start seeing clinical trial patients within some of Walgreen's locations?   Janet Kennedy: (05:26) All right. So let's go back a little bit to joining Walgreens in clinical trials. This is very new for them and you are in a very new group at Walgreens, are you not?   Adam Samson: (05:37) Absolutely. Yeah, you're correct. So about seven months ago, actually I might even take a step farther back than that and say spring of last year, we had our new - no longer new, I guess - CEO, Roz Brewer, joined. And Roz, very quickly - I believe it was by, by fall of last year - announced that we were moving into the healthcare space with the offering of Walgreen's Health. As part of that vision that she had, right? Overall moving to a more interoperable health type framework to ensure for our patients, our main constituents here at Walgreens, that we were not decoupling them from their healthcare providers, but really helping to bridge that care continuum. Part of that offering, they realized clinical trials could be part of this, right? So about seven months ago, my boss, Ramita Tandon, our Chief Clinical Trials Officer, joined the team, joined Walgreens Health, and she began to lay the framework for what this clinical trial business would look like. What services we might offer to begin with, what are the key roles that we needed leadership to get going?   Adam Samson: (06:50) And then Ramita, a couple months ago started bringing on other folks like myself. So I've been with Walgreens - I believe this is the end of week six for me - we've had some folks on a couple weeks longer, or a couple weeks less than me, but we're coming from different backgrounds. We have folks on the product side, we have folks who are really accustomed on digital optimization and how do we engage with patients in a meaningful way, making sure that we leverage our footprint to engage with folks in diverse communities. so really exciting to be part of this new and growing team.   Janet Kennedy: (07:29) I am both thrilled and awestruck for a huge company like that to make such a big move is amazing. And I keep thinking, you're trying to move a tank when the industry needs to be on motorcycles. That might be a horrible analogy, but it's a huge company you said over what, 7,000 locations within five miles of individuals. So how do you do that? Are you cherry picking certain markets or certain states where you already have some of those type of services in play or is this literally you're starting from a blackboard and you're just starting from the very beginning.   Adam Samson: (08:09) Yeah, it's a really good question. And honestly kind of going back to when I first saw the opportunity open up here for a position with Walgreens, my first thought similar to years I think was how could this possibly happen as a company so big, right? how could you possibly get something this big done, and after a call with Ramita, it was quite clear to me that Walgreens was very much invested in this, but also that they had the leadership team Ramita included to really make this happen. I've been blown away since I've joined at not just our small core group that is starting, but outside of that, in the Walgreens ecosystem, just a lot of excitement around Walgreen's health and clinical trials in particular. So obviously we're part of this larger company, but we are somewhat entrepreneurs, right?   Adam Samson: (08:54) We are being given the opportunity to start something new within a very large business and allowing some flexibility around how we might be able to make sure that we can do that in a way that is both effective and compliant, but also nimble. Now 9,000 stores - obviously we're not gonna try and open them all at once and, and activate them as clinical trial sites. The biggest thing on my mind right now is I'm traveling to a number of different locations. We have other folks on our team who are as well meeting with stores, understanding capabilities. We have identified already a number of stores that really are the ideal kind of first step, if you will, to be clinical trial sites. So we have a few investments, key investments that we've made, and some companies that I'll talk about that will really support that.   Adam Samson: (09:47) And also, I will say that Walgreens has, we've started building out what we call health corners. So this has already been happening for a year. Plus health corners are a place where there are a small physical footprint within a Walgreen store. That's staffed with a registered nurse or a registered pharmacist. They have private health rooms and they have places to interact with technology. And it's a place where our patients can go and they can have deep discussions that can help them with chronic care. They can have blood pressure drawn, maybe they could have, blood taken, these type of things to help with chronic disease management and others questions that might come up. Our idea first is to leverage these existing capabilities, as you can probably draw the connection there, right? We've already got nurses, we've got a private health space.   Adam Samson: (10:39) So we're gonna use that and make sure that we put trained clinical research professionals in place to support these activities within these spaces and support them with centralized staff as well. Now we don't wanna stop there. we don't wanna be limited. Now we are somewhere in the range of 200 health corners. I believe by the end of the year, we don't wanna only focus there. As I mentioned, we have some, some other key partners. One is village me medical or village MD. So village MD is actually a primary care offering in a community based setting. And these will be co-located with Walgreen. So this is actually 3,200 square feet of a Walgreen store that will be dedicated to primary care staffed with physicians and other clinicians. So this is another great opportunity for us to be able to leverage the existing Walgreens Health enterprise, to be able to plug clinical trials in make sure that we're doing it in compliant way, but utilizing the existing infrastructure.   Adam Samson: (11:38) There are some other exciting partnerships we have with Shields Health and specialty pharmacy, as well as CareCentrix in post-acute and, and home care. But as far as the physical space and building that out, that's where my focus is right now. How do we activate existing health corners and Village MD, but also looking at our our physical footprint that's out there that has private health rooms because of the immunizations. We administered approximately 63 million COVID vaccines. These spaces are already being used for healthcare purposes. How can we staff those stores and make sure that they are compliant to do certain clinical trial procedures, lots to think about long winded answer there, but really, really kind of cool work to start conceptualizing.   Janet Kennedy: (12:27) I've spent a little bit of time in the shopping center industry. So I feel like I've got a grasp of retail space issues and questions. And let me ask you this. A lot of the Walgreens, I would imagine in more rural or suburban areas have lots of space, but not necessarily in downtown Atlanta or downtown Raleigh or downtown New York city, are you gonna be able to find the space you need in those urban populations, which also are in areas that wouldn't be dealing with underserved populations?   Adam Samson: (12:58) Yeah. And I'm glad you mentioned that too, because this is as we've been very public about in our announcement, one of our biggest focuses right now is making sure that as we are opening up these type of health corners for healthcare purposes, but also our clinical trial purposes. So more than 50% of Walgreens stores are in socially vulnerable areas. And right now there is a huge push in industry and for very good reason to increase, diversity and inclusion within clinical trials, as we're looking at potential locations of where do we start doing this? We're not making it easy on ourselves. We're not, yeah. Let's, to your point, right, go to just the stores with the highest volume or anything. We're very much focused on going into places where there is not as much access to clinical trials or healthcare overall, and areas that are in communities that are overall just underserved. We have already started having these discussions with the the regional managers to identify those stores where, to your point there's only so much retail space or pharmacy space, and this is another thing that we're bringing into stores.   Janet Kennedy: (14:08) Well, you know, I'm wondering about how you're finding out what the needs are. Have you been in communication with some of the larger pharmaceutical companies in a, a, what if scenario, you know, if this were available, what kind of things could we bring to the table? What would you need to get from us? Obviously, patient records are a big part of what you have and also from the geographic location. I mean, so often now clinical trials are done where the principal investigators are. And a lot of the principal investigators are in larger city centers where there are medical centers and universities. How do you balance those needs with what do you actually have to have for the space to conduct a clinical trial?   Adam Samson: (14:51) Great question. And so, yeah, when it comes down to it and what I've spent a lot of the past two years prior to coming to Walgreens doing is trying to figure out how can we leverage some of these new models, right? So how can we leverage, not necessarily even fully decentralized hybrid type models. And we're looking at that with Walgreens too, right? How can we potentially have something at something like a Village MD where there's primary care and physicians and have kind of a hub and spoke model potentially right. Where we would have a PI within a certain region that might be conducting activities within a larger clinical type site, but then have within perhaps a 40 or 50 mile radius, we have X number of Walgreens locations and patients are able to go there for perhaps some of the follow up, right? They can meet with coordinators and have their blood drawn. They can have assessments done, and then if need be, they could come into the to the larger, location for certain procedures throughout the course of that trial. So looking at it in a very broad way and saying, we need to make sure that there's that PI oversight. How can we enable that though over a bit of a larger distance through centralized administrative support, as well as really best in class technology,   Janet Kennedy: (16:07) As I think about a Walgreen's on every street corner, what about the idea of the local Walgreen staff actually going to the patient to their home? Is that something you've discussed?   Adam Samson: (16:18) So we are absolutely looking at also as an option, not just in store, but also bringing this at home, in a doctor's office via mobile app. So we will be in addition to the existing Walgreen staff, which we very well are looking at opportunities for folks to be upskilled into clinical trials. We will be partnering with folks like, those that we have potentially over at CareCentrix and others that are accustomed to working within patients homes so that we can offer that as a service as well, where we could if it's permitted by the protocol, be able to, rather than have patients come all the way into a larger clinic or even to have to drive 10 minutes down the road to a Walgreens that we could potentially go out for certain things like blood draws and other things, and be able to see patients in their home, especially for those type of conditions patients might have where it makes access to clinical trials has decreased because of decreased mobility.   Janet Kennedy: (17:16) Now, the patient is obviously an important part of what we're talking about because that's one of the reasons that clinical trials do struggle that it isn't wrapped around what the patient needs, what the patient expects and how to support them best. Have patients been involved in these kinds of conversations, has Walgreen committed to any kind of patient advocacy committee group or focus group or anything of that sort?   Adam Samson: (17:41) Yeah, I mean, it's very early days, I will say, right. So we did launch just last month, but I am thrilled that we have on board, some folks like Kendal Whitlock who comes with just vast experience in this area, right? Working with patient groups and ensuring that we get that type of representative voice within our research program. we're also talking some other organizations right now that I can't share publicly just yet. but really positioning ourselves very early on. Like I said, we're only a month or so in since our launch to make sure that we are not assuming what our constituents and what our patients want, but making sure that we're hearing directly from people within the communities. Another thing just to kind of bridge off of that is we're looking at not just how do we inform Walgreen's patients and customers about clinical trials that, that might qualify for them, but also how do we kind of help the industry and our patients with this grassroots basic general clinical research, understanding and education, because as you well know, the barriers in a lot of these communities to clinical trials is either a lack of understanding or a lack of trust.   Adam Samson: (18:56) And if we just go in and, and start advertising clinical trials and every single Walgreens, I don't think that that's really gonna solve the problem. So we wanna be able to do some of that foundational clinical trial education through our pharmacist, through, through other staff to really start to build those connections with patients and hear from them so that that can help us inform our strategy.   Janet Kennedy: (19:21) Well, that's really exciting because aside from the two things you already mentioned, just awareness that a patient could be eligible for a clinical trial is a real challenge. So I think the opportunity that you have to make folks aware that it's happening on my street corner is a lot different than, you know, what a lot of patients experience. And certainly if there is at all, a silver lining to the pandemic is that I believe people became aware that clinical trials are an essential part of forwarding health and forwarding the learning about drugs and new ways to deal with illnesses and diseases. So hopefully people have also understood that it is a process that while doesn't happen overnight, we were able to escalate that during the pandemic, but that it's essential that we have patients a part of the process.   Adam Samson: (20:16) Absolutely. Yeah. And this idea of trying to assume what patients might want or to kind of do those checkbox activities of like, oh, well, we talked to a patient. I think, as an industry we're, we're moving past that. We're understanding that this is more than that, that we really need to engage in a meaningful way and that it's not a one and done kind thing. And I've been really glad to see that Walgreens very much is taking that approach to everything. And across the Walgreens health platform we have 160 million approximately lives that we service through Walgreens. And the trust that we have with those customers and those patients is something that is really first and foremost to Walgreen. So as we look at things like supporting, recruitment, as part of clinical trials, looking at insights gained through real world evidence, we have a really robust foundation around regulatory and privacy to make sure that we're not in any way violating that trust. And we're giving our patients, our customer the opportunity to opt in and opt out of these type of things. So that it's again seen as something that we can engage with them on, in a way that works for them, get their feedback. But if they're not interested also be able to not push the issue beyond the point where it should.   Janet Kennedy: (21:44) Absolutely. I think that should be the tenant of any healthcare organization patient first and what are they going to be comfortable with? Well, I'm really excited that I was able to capture you so early and fresh in your experience with Walgreens and at the very beginning of your more public announcements related to getting involved in clinical trials. And I'm not gonna put you on the spot per se, or hold you to this, but what does it really mean? What's it gonna take to get you up and running? And, and when will the first clinical trials be supported at a local Walgreens   Adam Samson: (22:19) We're shooting for this year, right. We, we want this to take months, not years to get off the ground. There's already, as I mentioned, been some groundwork done even before this initial team has started, there's been some really great work done by folks here at Walgreens to make sure that we're gonna be able to roll this thing out in a very compliant way. And now we got the folks on board that are needed to really start executing. And we're not starting from zero as well because we have as I mentioned, some physical locations that are very well staffed and set up to be able to support clinical trials. So we don't wanna rush, we do wanna walk before we run, but we anticipate that this year we will enroll patients within, a small number of clinical trials and start to get the wheels moving on this and then learn and, and build over time to be able to offer an increasing number of services and to be able to, service protocols of increasing complexity. So yeah, I would say, and expect by the end of the year to hear that we've had our first patient in store and certainly even before then, that we're, supporting recruitment in different ways as well.   Janet Kennedy: (23:27) Oh, that is very exciting. Well, I look forward to not only catching up with you in six months, or a year and finding out how things rolled out, but also speaking to other members of your team, hearing maybe a little bit more about how real world data and real world evidence will be incorporated into the programs; how patient engagement is going. So let's continue the conversation and thank you very much for being a part of People Always, Patients Sometimes.   Adam Samson: (23:54) Absolutely. Thanks so much, Janet for the opportunity. I look forward to reconnecting, and thanks so much everybody who listens.

This week we listen to a witch explain to us that magic isn't scary. Good to know. Has anyone noticed that the people who are the worst at life are the first to dish out advice to everyone else? Cros stops by to expose Laura Beth Finley as both a grifter and a bad parent. After watching her TikTok "dances" we move on to Patty C Cups who did us all a solid and recorded the first episode of Free Water in two months. It's a tremendous return to form for the world's most prolific podcaster. Stuttering John and his guest then explain the rules of comedy and using the r-word. And we finish things up with a game of Who Said It (racist edition) and Vic opening her shirt. Did I mention you can watch these shows unedited when you sign up for Patreon and Supercast? Support us, get bonus episodes, and watch live every Saturday and most Wednesdays: http://bit.ly/watp-patreon  https://watp.supercast.tech/ Come see us in Detroit: http://watplive.com  Learn more about your ad choices. Visit megaphone.fm/adchoices

Dennis and Brady make the final stop on their camp tour, where they talk to a ton of Pioneer players, a couple coaches, and preview the Cros-Lex football season!

Our very first ever Tough Talks Podcast guest is back for a cameo! But this time he's different. He's had quite the transformation in the last 5 years since that first ever episode. Now he's “Half Monk, Half Assassin.” Before I think he was a bit more of the assassin. His name is Jon Hunter and he has lived his entire professional career in the world of Enterprise Software Sales and Sales Leadership. He's a CRO and an advisor. He's a husband, father, brother, leader, coach, sports enthusiast, movie buff, martial artist, writer and podcaster. And he has spent his entire life committed to his own development, growth, excellence and impact. Our discussion today is primarily directed and dedicated to the CRO's and Sales Leaders of the world. We discuss the unique pains that come with those roles and Jon's insights on how to not just survive the loneliness of it, but how to THRIVE amidst that chaos! More about Jon: Website: www.hunterxlife.com LinkedIn: www.linkedin.com/in/jhunter1 Link to the episode: https://christopherdorris.com/tough-talks-hey-cros-you-dont-have-to-be-alone-with-jon-hunter/ --- If you enjoyed this content and you are not getting notifications of new posts, then I invite you to sign up to my list. Please also share this with the people in your world that would also dig this post and benefit from it. --- https://christopherdorris.com/lists --- Send in a voice message: https://anchor.fm/mental-toughness-podcasts/message

Sometimes you just gotta break some glass. That's just a sign that you're moving fast.  For large, prolific companies, the ability to continually grow is predicated on the ability to continually innovate. If you don't do this, the company will stagnate. That goes for partnerships in the public sphere as well. Libby Greco, Vice President, Alliances at Salesforce, talks about her many years of experience in keeping focused on the bigger picture, even as the times and arena she's played in, have changed.  Join us as we discuss: Co-selling ISV joint solutions appExchange   Here are some additional episodes featuring other ecosystem leaders that might interest you:  #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.   Links & Resources  Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds  To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com   This episode of Ecosystem Aces is sponsored by WorkSpan.   WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline. 

Raman Sehgal has made a career out of putting his energy— and he's got a lot of it— into building biotech outsourcing companies and the people who make them run. After years spent supporting several from within, he launched ramarketing, a firm dedicated to helping CROs, CDMOs,  CPOs, and other providers to the biotech ecosystem build their businesses, in 2009. He's also an international best-selling author (The Floundering Founder), co-founder of life sciences recruitment firm Lead Candidate,  and founder & host of the Molecule to Market podcast. On this week's episode of the Business of Biotech, Raman brings us his unique and multifaceted perspectives on the biopharma outsourcing space, the bear biotech markets, and how both are impacting the work of early- and clinical-stage biopharma leaders. 

ER DET URBAN AT VÆRE PÅ FESTIVAL? Cros eller AirForce?Backstage Lounge vs. camping?Hvor længe må der gå, før man går i bad?Er det okay at flirte?Må man bolle i telt?Hvad med at hoppe over hegnet eller blive afleveret på pladsen af sine forældre?Vi sætter krydderi på spørgsmålene live fra årets 50. Roskilde Festival sammen med vores elskede venner, Hav og Kamal!Få din festivalnostalgi på her i dagens energiske afsnit, inden hverdagen for alvor rammer os igen. God lyttelyst ♥️ Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Evelyn Kelly, Chief Executive Officer at Orphan Drug Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Evelyn, covering: A deep dive into the world of orphan drugs, rare diseases and personalised medicines including the background, evolution and fast growth of the area. The revolution in drug development that we are living right now and what this means for CROs, CDMOs and vendors in the space. The scary phase of being a start up along with the importance of having purpose as your motivation and being prepared to step-up. The non-covid impact of covid of the health of the population and the set-back it caused for small biotechs. Pearls of wisdom for ambitious young female leaders navigating their careers in the pharma and biopharma space. Evelyn has over 15 years' experience in the pharmaceutical industry in both distribution and orphan drug companies, working across supply chain, quality assurance and management roles. Evelyn brings years of experience in manufacturing and distributing orphan and speciality drugs to over 50 countries globally.She specializes in the management of supply via virtual, outsourced models and has been named as both a QP and RP on multiple licenses. She has held various positions in Shire, NPS Pharma and PTC Therapeutics and has designed and ran successful supply chains for different products.Evelyn founded Orphan Drug Consulting in 2017, with the vision of supporting companies across the drug development cycle. She holds a Master of Pharmacy from Robert Gordon University and a Master of Business from the Irish Management Institute. She also acts as Adjunct Associate Professor for the School of Pharmacy, Trinity College, Dublin. In 2022, she was named as a finalist in EY Entrepreneur of the Year. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

What can we do to tackle the workforce shortage in clinical research? This episode Judy Galindo and Monica Cuitiva, co-founders of Latinos in Clinical Research, join us to examine the potential solutions. During the podcast, the pair explain why education plays a pivotal role in raising awareness of the industry's potential, why sponsors, sites and CROs need to hire more entry-level staff, and emphasize the urgency for more resources to help train and retain staff."Online trainings are excellent, but also hands-on exposure; shadowing coordinators, research assistants, various other positions within – that's the training that's required to bring these people on, a combination of both."

The job description for a chief revenue officer at a media company doesn't resemble what it used to a decade ago. “There was a time where the lion's share of my job was just going out on sales calls,” said Mia Libby, revenue chief of The Daily Beast, who's held that position for nearly five years. That was back when she considered the CRO title as more of the head of ad sales given the fact that advertising was the primary source of revenue for the company. Now, about half of her time is spent in internal meetings with the product, editorial, audience and subscription teams, in addition to sales, to find a healthy balance of how advertising, subscriptions, licensing and commerce all work together, Libby said on the latest episode of the Digiday Podcast. Heading into 2022, The Daily Beast wanted to find a more efficient method of monetizing the site's users, from one-time visitors to paid subscribers. This meant creating more of a pipeline for converting readers to subscribers, but also by finding ways to collect first-party data in the process. With an economic slowdown creeping up on the horizon, however, Libby said that strategy is being looked to as the way of withstanding the potential headwinds, which could last a lot longer than the pandemic-induced recession of 2020. This episode marks the first of a four-part series on the Digiday Podcast, which explores how media CROs are leading their companies through turbulent times and are taking on new responsibilities as companies batten down the hatches with new revenue streams.

The easiest way to know whether a partnership is good is to make sure everybody gets what they want.  Sounds simple enough but the most promising thing any partners can do to be successful is having collaboration early on where stakeholders can be transparent about what works for them and what doesn't. A great side effect of that is building and maintaining relationships for years to come. Richard Wrbanek, Vice President, Strategic Partners & Alliances, Americas at OpenText, is here to discuss his perspective on what's made all the difference to strong partnerships.  Join us as we discuss: Building trust Communication Co-selling - bringing sales teams together    Here are some additional episodes featuring other ecosystem leaders that might interest you:  #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.   Links & Resources  Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds  To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com   This episode of Ecosystem Aces is sponsored by WorkSpan.   WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline

Although it's hotly debated, sales leadership seems to be emerging as a staple position in the career path to CRO. But at what cost? In this episode, Warren and Lupe are joined by Serkan Honeine, Chief Revenue Officer @ Certn. They chat about how deeply roles other than sales leadership can uniquely qualify you to lead revenue, how leading an international team from the other side of the world can be simple, the biggest challenge CROs face (and the cause), why you need to find metrics that matter, and the power of saying thank you in the remote-first world.

Who owns the clinical trial data generated in industry sponsored or investigator initiated clinical trials? What responsibilities do Sponsors, CROs, or Sites have when it comes to sharing clinical trial results with patients? Should a Sponsor get access to patient data collected outside a clinical trial setting? To answer these questions and more, I invited Darshan Kulkarni to the show. Darshan is a regulatory attorney specializing in FDA law, professor, author, and speaker. He is currently the Principal Attorney of Kulkarni Law Firm where he focuses his practice on providing healthcare companies with legal, compliance, and regulatory advice. He has led rare disease pharmaceutical companies in developing global programs to foster clinical trial transparency and enhance public health. He serves on the editorial board for Applied Clinical Trials at Advanstar Communications serving as a legal advisor on the clinical trial industry.  Previously, Darshan was on the editorial board of cosmetics and personal products for FDAnews where guided the publication with his clinical trial and pharmaceutical expertise. Last but not the least he is the host of the DarshanTalks livestream interviews where he discusses issues that impact the life science industry. This podcast is brought to you by Florence Healthcare. The learn more, please visit florencehc.com  

Medical Imaging in Clinical Trials with Elizabeth Dalton In this episode, I'm excited to talk about medical imaging in clinical trials.  We'll discuss the role of a medical imaging CRO, imaging endpoints in clinical trials, expensive mistakes to avoid as a trial Sponsor/ CRO, saving money on medical imaging services, imaging data collection process, and more. The guest for today's show is a long time friend of mine, Elizabeth Hartunian Dalton, Vice President at Calyx.   Liz is a seasoned clinical trial professional with 17+ years of experience working with sponsors, sites, and CROs in centralized medical imaging and clinical trials. Driven by a passion for service, Liz's ethos is rooted in honesty, productivity, commitment, and the power of positive energy.  In addition to her primary role of growing the Calyx partnership/CRO channel, Liz leads a team of technical solution consultants and is a medical imaging consultant herself.  Liz attended the University of Massachusetts where she achieved dual Bachelor degrees in Anthropology and Economics (magna cum laude) and will graduate in May 2023 with her MBA from Boston University's Questrom School of Business.  Please join me in welcoming Liz on the Clinical Trial Podcast.  This episode is brought to you by Calyx. To learn more about Calyx, please visit https://www.calyx.ai/ 

In this 58th episode of "The Weekly Bioanalysis" podcast, Dom and John wrap up their 2-part series on the Evolution of Bioanalysis, as they dive into the history of their bioanalysis careers by reviewing Drug Design and Development, and how that has effected the things CROs like KCAS do today. They discuss where the pharmaceutical and biopharmaceutical industry has been, and work their from 2010 or so to the modern day lab space - and even a bit on what the future may hold in the space."The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.

What if E.T. was never able to phone home and wound up stuck on Earth? And what if, after years of hearing people speak English, E.T. could kind of fake sounding like a person? And what if E.T. then idolized Joe Rogan and started a podcast? Well, it's all 100% real and this week we dig into it. Cros is back on the show to prove Fiji Water is not a real sponsor of MSCS Media. Then we hear Opie call us out, reminisce about the Patty C Cups of yesteryear, and get the latest on John's newsworthy cease & desists. Also, I know this is an audio-only show but Vic's top is really on point on this one. Nice work. Support us, get bonus episodes, and watch live every Saturday and Wednesday: http://bit.ly/watp-patreon https://watp.supercast.tech/ Tickets for the roast: http://creepoffroast.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Chaque week-end, nos correspondants aux quatre coins de la France répondent à une question simple : Que se passe-t-il chez eux aujourd'hui ?

In a role as complex as the CRO, it's impossible to have expertise in every area. So, how do you respond right when you're entering a new territory. In this episode Warren and Lupe are joined by Todd Heger, CRO @ Digilant. They cover why coachability and humility are essential skills for CROs, the power of seeking advice, a quick hack to diffuse team tensions, the importance of managing talent, and why you need to insist on transparency during the interview process.

In order for the ecosystem to function at its best it needs to include not one, but multiple partners. The best way to do that is to work with partners who are willing to share the risk, innovate, and stay flexible for future technologies. Suresh Kumar Tulluri, Vice President & Global Head - Ecosystem Business Unit at HCL Technologies, talks in this episode about how to bring the customer along for that journey and the need to stay prepared to move not only forward, but occasionally sideways as well. Join us as we discuss: Roadmap innovation Investing in tech ISVs, Red Hat, VMware Private networks to verticals, HCL, CSP, Intel, and more Here are some additional episodes featuring other ecosystem leaders that might interest you: #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.  Links & Resources Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds   To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com   This episode of Ecosystem Aces is sponsored by WorkSpan.  WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline.

In a previous ABM Done Right Podcast, Mark Stouse (CEO of Proof Analytics) mentioned that there is a near-total misunderstanding about the purpose and focus of a great ABM effort. Kristina and Mark discussed how ABM has wrongly become synonymous with ABM tech, how ABM using 3rd party data is only DM on steroids, how ABM measurement is off target, and how most ABM programs are creating headwinds for sales, slowing deal times and lowering deal sizes.   In this podcast, Kristina Jaramillo shares:1. How a sales and marketing AI firm that focused on positioning and messaging was not doing ABM - just pockets of account-based activities.2.  How you cannot effectively execute ABM without starting with a hyper-personal 1:1 ABM program.3. How most ABM programs are nothing more than targeted demand gen using intent data.4.  How ABM firms and many leaders wrongly believe that you can retrofit ABM.5. How many teams still think of funnels when there's nothing funnelistic about ABM. 

Joel White is an independent consultant who founded Marketcap Consulting in June 2021 to help organizations, particularly those in the clinical research industry, improve their pricing, profitability, cash flow, and financial operations. Previously, Joel worked for about 15 years across large and small CROs leading various functions in proposals, pricing, finance, and contracting. In this episode we discuss so many site level budget and contract issues including pricing, cash flow and contract negotiations. This episode is packed with value for research sites.

Creating demand for your product is more than just selling a product.   You want customers to be the biggest advocates of your product. Having the right integration and partnerships at every level not only create a reliable service, but create fans who will take your products and run with them themselves.   Listen in as Akhil Kapoor, Vice President of Technology and Cloud Partnerships at New Relic, Inc. discusses his team's tried and true strategies for building the perfect ecosystem that will have customers coming back for more.  Join us as we discuss: Hyperscalers What it takes to be successful with cloud providers Solution development How to go to market  Here are some additional episodes featuring other ecosystem leaders that might interest you:  #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.   Links & Resources  Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing. Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds   To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com  This episode of Ecosystem Aces is sponsored by WorkSpan.   WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline.

The emerging role of the Chief Revenue Officer (CRO) has become one of the most talked-about topics in B2B sales this year. But, when it comes to truly knowing how to position and leverage a CRO to help a sales organization scale, this is where many modern sales companies are struggling. The key to the success of a CRO comes from not just the path they took in their career but from their ability to align teams across all departments and tap into technology to enable progress and productivity at all levels. What CROs should be doing and how companies can strategically use this role to scale is the topic of discussion in this episode of the Modern Selling Podcast. My guest, arguably one of the best CRO experts and consultants in the industry, shares his incredible insights to prove that when done ‘right' a CRO can be the winning advantage to take your sales organization to the next level. Ed Porter is the Chief Revenue Officer of Blue Chip CRO. His stellar 20+ year career has led him to manage teams of varying sizes from 5 to 1,000+ people with responsibilities for sales, customer experience, revenue operations, and marketing functions. Ed has worked for service, software, and distribution companies learning the foundations of delivering a powerful customer experience while driving value and effectiveness in the sales and development channels. He has participated in, facilitated, and chaired several executive groups centered on sales management, contact center management, and technology innovation. As a keynote speaker and guest speaker focused on several key sales strategies and customer management programs, Ed has been recognized as a two-time Top 25 Most Influential Sales Leader, Executive of the Year, Excellence in Execution, Top 100 Sales Coaches to Watch, and a two-time Chapter of the Year award winner for AA-ISP. Currently, Ed is a fractional chief revenue officer providing coaching and strategic planning services for executives and startups, helping them rethink and refocus revenue strategies to accelerate growth. He helps clients align their revenue teams — marketing, sales, enablement, and customer success — to build accountability at every step of their organization, leading to accelerated and sustainable growth. Download the full conversation to get clear on what and how a CRO should be contributing to the growth of your sales organization. What is the Real Role of a Chief Revenue Officer? We often hear CRO thrown around, but few have truly defined what the role is and, more importantly, what they should be responsible for. I wanted to get Ed's perspective on what he believes makes a CRO role work and if every B2B sales company needs one, in order to thrive in this post-pandemic environment. His insights are spot on, “The CRO must own everything revenue. Not just one part, but all parts. Because in order to really be the one that owns all parts of revenue, you need to own the full buyer lifecycle. Which means owning marketing, owning sales, and owning everything post-sales too like customer success.” There has always been a growing divide (I've seen) between sales, marketing, and customer success. So, it was interesting to hear that Ed believes they must all live under the same C-Suite role in order to drive the customer forward. In my 20+ year career in B2B and B2C sales, I've found that even for CROs that may not have robust marketing or sales or customer success background, they're still able to build amazing synergy within their organizations as long as they know how to leverage the right training, technology, and systems to bring their teams together. And, technology and training are a large part of what Ed shares in the first half of our conversation. Listen in to hear what he suggests every CRO do to ensure that their teams are successful. How Do You Actually Align Sales, Marketing, and Customer Success Teams Together? At Vengreso, we intentionally build in alignment between the teams. We have regular huddles and syncs for the departments to share what's working respectively, so we can establish a cohesive collaborative approach. Based on Ed's experience working as a fractional CRO, I wanted to hear his insights on what works to align teams for a CRO to be successful and what skills he believes a CRO must have that they can't necessarily be taught. Ed explains, “Traditionally, CROs have sales experience and come from that world. But, that often means they're light on understanding marketing and customer success. And, that's ok. I would argue that the path someone takes to become a CRO is irrelevant. It has less to do with their area(s) of expertise and everything to do with the person. You don't have to have run sales, marketing, or customer success departments to be a highly effective CRO. But, you DO have to be a great leader.” I found this point to be quite interesting. Here at Vengreso, we often cross-train our sales teams to be involved in not just one department, but in several. We've found that this enables our sales reps to approach the sales process very differently. They're able to think about the impact that marketing has on sales, or that sales have on customer success. This is such a powerful alignment (when done right), that would enable any sales organization to work as a seamless machine, rather than a bunch of separated silos. Join the conversation and get even more insight on how Ed recommends sales, marketing, and customer success teams work together. How Does Technology Empower the CRO?  This is always an area of interest, especially for sales leaders. As I always say, “a fool with a tool, is still a fool.” I've found that all too often, B2B sales organizations implement a host of different pieces of technology across each functional area. So, what the sales and marketing teams may be using may not be integrated. And, the customer success teams could be using something entirely different. It's this disconnect between teams (further exacerbated by the technology stack they're using), which makes it hard for anyone to truly talk to one another and gain key insights. That's why with our FlyMSG text expander plugin, we've seen users achieve tremendous growth and synergy. Now, they're able to have a way to send consistent messaging across departments and be in better alignment to attract prospects and convert them into customers. FlyMSG is just one tool Ed and I discuss in this conversation that can catapult sales teams to a new level. Listen in to the entire episode to see what other technology and tools we see working to bring teams together.

Clari CEO Andy Byrne says he never wants to look back and see that he put more into his work than his family. But that doesn't mean he can't learn a thing or two from running a 600-person multi-billion dollar business: Inspired by business books, he and his wife Julie set goals, methods and OKRs for their family, and even asked their kids to grade them on how well they were hitting their targets. “I feel like our job is to help our families realize their fullest potential first, and then work is second,” Andy says.In this episode, Andy and Joubin discuss buying homes in San Francisco; leading a company when you have tragedy in your personal life; Man's Search For Meaning; internal vs. external expression; machine learning in enterprise; the “golden triangle” of reps, managers and execs; Andy's legendarily effective board meetings; how constraints create opportunity; and the metrics of marriage.In this episode, we cover: How luck makes you look smart (04:47) The “dark year” in Andy's life and coping with negative stimulus (09:51) Reframing seemingly huge problems as moments in time (16:27) How Clari helps CEOs and CROs answer “the most important question in business” (22:45) Getting from product fit to go-to-market fit (27:14) Leading a 600-person company, and Andy's fiduciary duty to their families (33:49) Actually, the CEO is not “the loneliest job in the world” (41:14) Managing through — and leaning into — a market downturn (45:00) Why Andy and his wife run their marriage like co-CEOs (49:24) Living your life with intention (56:00) Links: Connect with Andy Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: grit@kleinerperkins.com  Learn more about Kleiner Perkins

Stuttering John and his best friend Scott the Engineer made a trip over to Tommy's house to do yet another drunken interview with Tommy from MSCS Media. I'd tell you to go watch it but based on the number of views it has on YouTube I have to assume you already have. Stick around to the end as we reveal how many beers John was able to gulp down during a single interview. Cros stops by to analyze Tommy's social media presence. After reading sentences that sound like they might be written in English, we uncover that Tony Michaels used to host a "business brainstorming" podcast (whatever that means) about digital marketing. Wow, we have discovered yet another thing that Tony Michaels sucks at. Also, Patrick Michael knows his show could be better and is doing what it takes to maintain his current mediocrity. Support us, get bonus episodes, and watch live every Saturday and Wednesday: http://bit.ly/watp-patreon https://watp.supercast.tech/ Tickets for the roast: http://creepoffroast.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

During the 57th episode of "The Weekly Bioanalysis" podcast, Dom and John have a chance to dive into their history of their bioanalysis careers by reviewing the evolution of Drug Design and Development, and how that has effected the things CROs like KCAS do today. They discuss where the pharmaceutical and biopharmaceutical industry has been, and work their way through to roughly 2010 or so by the end of this multi-part series (check back soon for the continued episodes as they move their way into the present day)."The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.

The customer doesn't just want to buy something. They want it to work.  Traditional GSP transactions tend to focus too much on revenue, and not enough about integrating partners from all over so that the customer isn't just buying something, but also using it.  In this episode, Michael Bruchey, Global VP Partner Solutions at SAP, shares his insights on making happier customers who are more likely to renew services and expand to other products as well. Join us as we discuss: Partner solutions that work globally and locally   Getting your customers excited about GSP Creating partners at all levels of a transactions Here are some additional episodes featuring other ecosystem leaders that might interest you: #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow   #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.  Links & Resources Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing.  Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partner ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds   To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com This episode of Ecosystem Aces is sponsored by WorkSpan.  WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline. 

By designing quality into trials, we focus on the most critical data and create a framework for efficiently identifying and addressing any risks to patients, the integrity of data, or regulatory compliance. While part of regulatory guidance, consistent interpretation of RBQM approaches by regulatory inspectors is an area of concern. In such a highly regulated industry that is notably slow to adopt change, biopharmaceutical companies and CROs are still debating how to go with evidence-backed documentation to satisfy regulatory requirements when using risk-based approaches. In the third episode of our RBQM podcast series, Amy Kissam-Sands, Senior Vice President of Clinical Operations, John Bell, Chief Quality Officer, and Dr. Kristin Murphy, Senior Director and Global Head of the Change and Adoption Center of Excellence, discuss how to work within the regulatory guardrails when establishing a risk assessment framework.

Today we're catching up with Dr. Heather Underwood, CEO of EvoEndo. EvoEndo recently completed an $8.4 million Series A financing round on the heels of 510(k) FDA clearance in early 2022. We first spoke with Dr. Underwood in June of 2021. In this episode, we chart a course through her accomplishments, lessons learned through the FDA clearance process, working with CROs, and hear firsthand about the challenges she's tackled as Chief Executive of a medical device startup ready to revolutionize clinical endoscopy practice with a safer, faster, cost-effective alternative. About EvoEndoEvoEndo, founded in 2017 by Dr. Joel Friedlander (Chief Medical Officer), is making unsedated transnasal endoscopy a reality. General anesthesia has been the standard of care for pediatric patients undergoing endoscopies. This can be a traumatic experience, especially for patients with chronic health conditions who may require the procedure several times a year. But EvoEndo's single-use small-diameter device for unsedated transnasal endoscopy is ready to transform this medical necessity. The company received 510(K) clearance from the FDA in February of 2022 and is poised for a commercial launch of its innovative product. About Dr. Heather UnderwoodDr. Heather Underwood joined EvoEndo as CEO in 2019 after completing the Stanford Biodesign Innovation Fellowship for medical devices. Dr. Underwood completed her Ph.D. at the University of Colorado Boulder's ATLAS program where she developed and implemented clinical decision support systems for midwives and nurses in Kenya, receiving the NSF Graduate Research Fellowship grant and a Gates Grand Challenges grant to support her research. She has spent the last 10 years founding and leading medical device startups, non-profit life science organizations, and innovative academic initiatives. LinksHeather Underwood | LinkedIn:https://www.linkedin.com/in/hmunderwood/ EvoEndo:https://evoendo.com/Titan100:https://www.titan100.biz/2022coloradotitan100Proxima CRO:https://www.proximacro.com/Qualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez 

It's our second mid-week episode and this time we feature one of our greatest accomplishments, Patty C Cups aka Patrick Michael. For a guy with many monikers and talents, he sure is consistently bad at everything he does. Cros comes over and gives us the highlights of Patty's last four or five episodes. After that, we check in with Tony Michaels' fast food vlog again. Then it's back to Patty and his karaoke stylings (just to torture Cros). Finally Vic joins us for no apparent reason and we listen to your voicemails. Support us, get bonus episodes, and watch live every Saturday and Wednesday: http://bit.ly/watp-patreon https://watp.supercast.tech/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Partnerships drive solutions.  If you have a goal to be everywhere, your business can get there by developing and nurturing real-world, end-to-end partnerships.  Today's guest, Glen Straub, VP of Business Development at Foursquare, has scaled 550 different partnerships across data, products, sales, distribution, and markets.  Join us as we discuss: What to look for when you need a partner to go to market with How to build an ecosystem of partnership culture in a company The value of partnerships forged and seasoned over time  Here are some additional episodes featuring other ecosystem leaders that might interest you: #121 Aligning Ecosystem Strategy with Your Customer as the North Star with Lara Caimi, Chief Partner Officer, ServiceNow  #122 There's No Easy Button For Partnering with Nicole Napiltonia, VP Of Alliances and OEM Sales, at Barracuda  #106 The Secrets to Managing Alliances Like Microsoft with David Totten, Chief Technology Officer, US Partner Ecosystem at Microsoft  #97 Why Quality Always Beats Quantity in Software Ecosystems with Tom Roberts, Senior Vice President at the Global Partner Organization over at SAP.  Links & Resources Learn more about how WorkSpan helps customers accelerate their ecosystem flywheel through Co-selling, Co-innovating, Co-investing, and Co-marketing.  Subscribe to the Ecosystem Aces Podcast on Apple Podcast, Spotify, Stitcher, Google Podcast.  Join the WorkSpan Community to engage with other partn er ecosystem leaders on best practices, news, events, jobs, and other tips to advance your career in partnering. Find insightful articles on how to lead and get the most out of your partner ecosystem on the WorkSpan blog. Download the Best Practices Guide for Ecosystem Business Management  Download the Ultimate Guide for Partner Incentives and Market Development Funds To contact the host, Chip Rodgers, with topic ideas, suggest a guest, or join the conversation about modern partnering, he can be reached on Twitter, LinkedIn, or send Chip an email at: chip@workspan.com   This episode of Ecosystem Aces is sponsored by WorkSpan.  WorkSpan is the #1 ecosystem business management platform. We give CROs a digital platform to turbocharge indirect revenue with their partner teams at higher win rates and lower costs. We connect your partners on a live network with cross-company business applications to build, market, and sell together. We power the top 10 business ecosystems in the technology and communications industry today, managing over $50 billion in the joint pipeline. 

We have a jam packed show this week from City Winery in Nashville. Cros, Trucker Andy, Producer Chris, Dr. Steve, Jenny Jingles, Vinnie, and Shuli all join us to discuss Stuttering John, Ash, Tom Myers, Patrick Michael, and many other retards. I know, live podcasts sometimes suck, this one's pretty good.   https://shalomshuli.com/ https://thecreepoff.com/   Support us, get bonus episodes, and watch live every Saturday: http://bit.ly/watp-patreon https://watp.supercast.tech/

Doug Bell, LeanData CMO, discusses the rise of CROs and the importance of rev ops to marketers. Wherever Doug Bell can take an activity that allows for the creation of short-term and long-term growth, he'll do it. The Revenue Generator podcast is LeanData's solution for brand awareness and demand generation. Today, Doug talks about why he decided to start a daily podcast. Show NotesConnect With: Doug Bell: Website // LinkedInThe MarTech Podcast: Email // LinkedIn // TwitterBenjamin Shapiro: Website // LinkedIn // TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Doug Bell, LeanData CMO, discusses the rise of CROs and the importance of rev ops to marketers. Rev Ops connects the data between sales, marketing, customer success to make sure people are operating efficiently. Does this function truly unify the organization's operations, or is it simply wishful thinking? Today, Doug talks about RevOps's potential for marketers. Show NotesConnect With: Doug Bell: Website // LinkedInThe MarTech Podcast: Email // LinkedIn // TwitterBenjamin Shapiro: Website // LinkedIn // TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Doug Bell, LeanData CMO, discusses the rise of CROs and the importance of rev ops to marketers. There's no denying that lines between marketing and sales have blurred considerably over the years. With the emergency of the CRO role, should CMOs be worried that they won't have a job very soon? Today, Doug talks about the emergence of Chief Revenue Officers. Show NotesConnect With: Doug Bell: Website // LinkedInThe MarTech Podcast: Email // LinkedIn // TwitterBenjamin Shapiro: Website // LinkedIn // TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dana Carvey and David Spade are hosting a new podcast about Lorne Michaels. They bring on guests who all do a Lorne Michaels impression. If you watched all three Austin Powers movies and thought, "I need more Doctor Evil" then this is the show for you! This week Cros drops by as we discuss the misery that is having Mike Myers as a guest. Then we get an update on the women who inspired the potato show, find out what Patty C Cups thinks about his new headphones, learn more about Stuttering John's totally real and not made up lawsuit, and finally learn about TikTok from Opie and Jackie the Jokeman. Get tickets to the Shuli Egar, Vinnie Paulino, and Vic stand-up show - whoarethesecomics.com  We're live in Nashville on May 14th, get tickets: https://bit.ly/watp-nashville Support us, get bonus episodes, and watch live every Saturday: http://bit.ly/watp-patreon https://watp.supercast.tech/